Senhance System to be placed at hospital in the Commonwealth of Independent States
Asensus Surgical, Inc., a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery, announced that a Senhance Surgical System was sold to the Company’s distribution partner, and will be placed in a hospital in the Commonwealth of Independent States (CIS) region.
AI and ML News: AI: Continuing the Chase for Brain-Level Efficiency
“We are excited to be partnering with yet another institution to initiate a Senhance program to deliver better patient outcomes,” said Anthony Fernando, Asensus Surgical President and CEO. “With the combination of unique instrumentation, including 3mm and articulation, advanced safety features such as haptic feedback, and the industry’s only intelligent Artificial Intelligence platform, Senhance provides the opportunity to revolutionize a surgical team’s capabilities when performing laparoscopic procedures.’’
Asensus Surgical’s technology platform, Senhance Surgical System, is the first of its kind digital laparoscopic platform that leverages augmented intelligence to provide unmatched performance and patient outcomes through machine learning. Senhance goes beyond the typical surgical robotic systems, providing surgical assurance through haptic feedback, eye-tracking camera control, and 3D visualization, and is the first platform to offer 3mm instruments (the smallest instrument available in the world on a robotic surgical platform).
Top Artificial Intelligence Insights: Could Instances of NLP Bias Derail AI?
The Senhance Surgical System is powered by the Intelligent Surgical Unit™ (ISU™). The ISU enables machine vision-driven control of the camera for a surgeon by responding to commands and recognizing certain objects and locations in the surgical field, and allows a surgeon to change the visualized field of view using the movement of their instruments.
Asensus Surgical, Inc. is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery by unlocking clinical intelligence for surgeons to enable consistently superior outcomes and a new standard of surgery. This builds upon the foundation of Digital Laparoscopy with the Senhance Surgical System powered by the Intelligent Surgical Unit (ISU) to increase surgeon control and reduce surgical variability. With the addition of machine vision, augmented intelligence, and deep learning capabilities throughout the surgical experience, we intend to holistically address the current clinical, cognitive and economic shortcomings that drive surgical outcomes and value-based healthcare
AI ML in Marketing: AI and Big Data Analysis Used to Find Brands’ Emotional Connection
[To share your insights with us, please write to sghosh@martechseries.com]
Comments are closed.